View the future of MedTech: Preview of equipment and diagnostics investments to go all out finalists
MedTech development is a fascinating area of medical care. From innovations in brain surgery and wound healing to detection of bacteria, viruses and diseases, MedTech innovations have transformative impacts on human health. At Invest is a boutique medical investor conference scheduled for May 20-21 at the Willis Building in Chicago, and the entrepreneurial competition Pertect Perfect is at the heart of the event.
Medical Equipment and Diagnostic Tracks are four of the Perte Perfect Perfect competitions. Equipment and Diagnostic Tracks The theme of this year is chronic diseases and their management. So far, the track’s judges include: Charity Tarn, an investor at Arboretum Ventures, and Jenni Le, head of the Venture Investors Health Fund. Here is a preview of MedTech that will compete.
To register for an investment and view the full agenda, click here.
Biometrics. Patented sensors and devices have been developed for people with asthma and COPD to determine the risk of attack 20 days before the onset of symptoms. According to the company's website, airway inflammation is measured by fractional exhaled nitric oxide using test strips and connected devices. Its technology is used to biologically determine the risk of attack, compliance, drug efficacy, and exposure to environmental triggers. Diagnostic data are enhanced through exclusive collaboration with the American Lung Association, digital solutions and evidence-based self-management programs.
To register for an investment and view the full agenda, click here.
Micro Leads Inc. Trying to help people with chronic pain, diabetic neuropathy, sleep apnea, urological diseases and migraines through its intelligent implant technology. Micro-Leads has developed “smart programmable electrodes” to unlock new implants. It uses sealed electronics in each electrode array. According to its website, the Shape-Memory Smart implant electrode is self-expanding, providing minimally invasive and injectable delivery paradigms by unlocking the treatment into a larger treatment area of 3x-5X.
Highland Musical Instruments Its electrical stimulation (ESSTIM™) was developed to meet unmet clinical needs in addiction, chronic pain and movement disorders. According to its website, its brain stimulation technology combines independently controlled electromagnetic and ultrasound fields to focus and enhance stimulation of neural tissue. In clinical trials, ESSTIM™ has been successfully implemented for the treatment of chronic pain. ESSTIM™ has also successfully implemented the treatment of Parkinson's disease in clinical trials and is currently under investigation for the treatment of opioid use disorders.
Leuko Labs Developed PointCheck™, the first device for non-invasive leukocyte monitoring. By eliminating the need for blood draw, millions of immunosuppressed patients can be tested more frequently, moving towards improved quality of life and improved clinical outcomes. It can be frequently monitored at home to improve clinical outcomes and quality of life in patients with cancer chemotherapy. The technology combines microscopy and AI to collect and analyze blood videos flowing through superficial capillaries. The risk of infection is a huge concern for patients with chemotherapy. PointCheck™ helps show when the risk of infection is elevated to help trigger preventive treatment.
Contact quickly Seeking to address unmet needs in healthcare: There is a lack of products that repair nerve damage due to peripheral neuropathy and wound healing products that treat surrounding nerves. Its technology is designed to provide microbial control and neural repair to ensure faster and more effective recovery.
XPAN It is desirable to use a minimally invasive procedure to reduce the time required for routine surgical closure. It has developed an expandable cannula card to reduce complications, resulting in faster recovery and higher versatility to reduce laparoscopic and robotic surgery. According to the company, the device has received the FDA clearance.
photo: champpix, Getty Images
